Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-18

Clinical Trial Update: Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of Nicotine [Phase 2]

View source ↗

Summary

Phase 2 study assessing high-dose transdermal nicotine for individuals who metabolize nicotine quickly; completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transdermal nicotine patch (Nicotine)

Snippet

Sponsor: University of Pennsylvania | Conditions: Nicotine Dependence | Phase 2 | Status: COMPLETED | Results posted: 2013-03-18